A change in the paradigm of antibiotic management in infective endocarditis: are we ready?
Eur Heart J
.
2023 Dec 21;44(48):5107-5109.
doi: 10.1093/eurheartj/ehad529.
Authors
Nuria Fernández-Hidalgo
1
2
3
,
Ignacio Ferreira-González
2
4
5
Affiliations
1
Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari, Passeig de la Vall d'Hebron 119-129, 08035, Barelona, Spain.
2
Universitat Autònoma de Barcelona, Barcelona, Spain.
3
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
4
Cardiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari, Barcelona, Spain.
5
CIBERESP, ISCIII-CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain.
PMID:
37930713
DOI:
10.1093/eurheartj/ehad529
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use
Denmark
Endocarditis* / drug therapy
Endocarditis, Bacterial* / drug therapy
Humans
Substances
Anti-Bacterial Agents